Abstract
OBJECTIVE: This study aimed to examine the current status of psychiatric therapy and anti-craving prescriptions for patients with alcohol-related diseases and to evaluate the impact of these treatments on the prognosis of alcohol-related diseases for drawing implications. METHODS: Data were analyzed by combining data extracted from one hospital, data of the National Health Insurance Service, and the National Statistical Office mortality data. The rationale for utilizing an integrated data set was that a single dataset from a single hospital was insufficient for comprehending economic factors, mortality rates, and medical information. RESULTS: The analysis yielded two principal conclusions. Firstly, concurrent administration of psychiatric therapy and anti-craving prescriptions was demonstrated to be an effective approach in the management of alcohol-related disorders. Secondly, the economic status of patients was found to influence outcomes of psychiatric pharmacotherapy. CONCLUSION: The integration of diverse alcohol-related data for management could facilitate the implementation of personalized prescriptions tailored to specific needs of each patient. This approach has the potential to reduce mortality rates and mitigate societal burdens associated with alcohol-related diseases.